Developer docs
API playgroundTry for free, no card

Search company profiles

GreenLab

Full company profile

uuid0000flz

Namestring
GreenLab
Legal namestring
GreenLab, Inc.
Websiteurl
greenlab.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

GreenLab is a plant-based biotechnology company headquartered in Jonesboro, Arkansas, that uses proprietary corn-based protein expression technology to convert cornfields into scalable protein manufacturing facilities. Its core platform, GreenLab Vector Technology (GVT), is a vector system that transfers and expresses recombinant proteins directly in corn plants at yields the company claims are up to 100X higher than traditional methodologies. The company has transferred nearly 20 proteins into corn, has four or more patented enzymes in commercial production, and has been developing brazzein (a naturally occurring sweet protein) as a sustainable sugar-replacement ingredient for food formulators.

GreenLab serves enterprise B2B customers across food and beverage, pharmaceutical/nutraceutical, energy/industrial, and environmental remediation sectors. Revenue mechanics are structured around licensing its protein expression technology, direct sales of proprietary proteins and enzymes, and strategic production partnerships (most notably the March 2025 alliance with AI-protein-discovery company Shiru targeting CPG customers). The GTM motion is enterprise field sales supplemented by partnership channels and a private investor/partner portal. Pricing is not publicly disclosed and is negotiated through custom B2B arrangements.

The company has disclosed approximately $5.27M in seed funding (January 2023, Northeast Arkansas agricultural investors) and an additional $1.91M round (April 2025), with stated total investment of approximately $8M to reach commercial readiness. The leadership team is anchored by co-founders and senior scientists from Agrivida (including CTO Michael Raab and VP Jeremy Schley-Johnson), with additional expertise drawn from Monsanto, Syngenta, Cargill, Nestlé, and Goldman Sachs. The company remains privately held with 1-10 employees and operates from a single U.S. location.

Short descriptiontext

GreenLab is a Jonesboro, Arkansas-based plant biotechnology company that uses proprietary corn-based protein expression technology (GVT) to produce sustainable proteins and enzymes for food, pharmaceutical, energy, environmental, and industrial B2B customers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersJonesboro, United States
HQ citystring
Jonesboro
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
plant-based protein production, corn-based protein expression, recombinant enzyme manufacturing, agricultural biotechnology platform, natural sweetener brazzein
Industry3 codes
1Plant-Based & Alternative Proteins (Packaged)
CodeCRADAAAHPrimaryYes
2Enzymes & Processing Aids (Baking, Brewing, Dairy, Meat)
CodeCRADAOAHPrimaryNo
3Specialty & Novel Proteins (Single-Cell Protein, Cell-Cultured/Animal-Free Proteins)
CodeAFAJAHALPrimaryNo
NAICS code1 code
  • Food Manufacturing311
SIC code2 codes
  • Food And Kindred Products2000
  • Medicinal Chemicals & Botanical Products2833
Product category
Plant-based Biomanufacturing
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Protein and Enzyme Licensing/Sales
TypeLicensing Royalties
Description

GreenLab generates revenue through licensing its proprietary corn-based protein expression technology and direct sales of proteins and enzymes produced in commercial corn production. The company sells its proprietary portfolio directly to partners and also seeks to expand manufacturing capacity for other protein manufacturers.

greenlab.com
2Partner Production Services
TypeManaged Services
Description

Revenue generated through strategic partnerships where GreenLab provides protein production optimization services using its scalable corn expression system. Partners gain access to high-yield, scalable manufacturing that extends beyond traditional microbial and precision fermentation approaches.

greenlab.com
3Technology Platform Licensing
TypeLicensing Royalties
Description

The GVT platform is offered to eliminate production backlog for protein designers and enzyme engineers, with collaboration opportunities for manufacturers to grow proteins to scale. The technology enables unlimited scalability over time.

greenlab.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

GreenLab develops and operates a proprietary corn-based protein expression platform (GreenLab Vector Technology, GVT) that converts traditional cornfields into scalable bioreactors for manufacturing recombinant proteins and enzymes. The company sells and licenses its corn-grown protein portfolio directly to enterprise customers, including the natural high-intensity sweetener Brazzein and multiple patented enzymes in commercial production, and offers partner production services for protein designers, enzyme engineers, and biomanufacturers in food, pharmaceutical, nutraceutical, energy, environmental remediation, and industrial markets.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 100X higher activity yields than traditional protein expression methodologies
+2 more records
Product overview1 text field

GreenLab is a biotechnology company that has developed a proprietary plant-based protein expression platform using corn as a biofactory. The company offers a unified platform technology (GreenLab Vector Technology) combined with commercial products including Brazzein (a natural sweet protein) and multiple enzymes. The platform transforms cornfields into scalable protein manufacturing facilities, enabling the sustainable production of high-value proteins for food, nutrition, and industrial applications. The company has successfully transferred nearly 20 proteins into corn and has multiple patented enzymes already in commercial production.

Product and service3 records
1Brazzein
CategoryNatural high-intensity sweetener (recombinant protein)
Description

A naturally occurring high-intensity sweet protein originally found in the West African oubli plant, sustainably produced through GreenLab's proprietary corn-based expression system. Brazzein is offered as a nutritive sweetener for food formulators and food service partners, providing production capacity, reduced sugar use with health benefits, and recipe formulation flexibility for CPG and beverage manufacturers.

2GreenLab Vector Technology (GVT) Platform
CategoryBiotechnology platform / Technology licensing
Description

A proprietary corn-based protein expression platform licensed to protein designers, enzyme engineers, and biomanufacturers across energy, food, pharma, environmental remediation, and industrial sectors. The platform enables yields up to 100X higher activity than traditional methodologies, offers unlimited scalability across acres of conventional cornfields, and eliminates production backlog by extending manufacturing beyond microbial and precision fermentation.

3Commercial Enzymes (Corn-Grown)
CategoryIndustrial and food enzymes (recombinant proteins)
Description

Multiple transformative enzymes produced commercially through GreenLab's patented corn-grown protein system. The company has scaled commercial production of several enzymes and currently has four patented enzymes growing in corn in commercial production, serving food, industrial, and animal nutrition applications.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-03-12
Description

Strategic partnership to commercialize novel food proteins using GreenLab's proprietary corn expression system. The collaboration combines Shiru's AI-powered protein discovery with GreenLab's high-yield, scalable manufacturing platform that extends beyond microbial and precision fermentation. Initial focus directed at CPG companies. Benefits include faster ingredient innovation, scalable cost-effective production, lower costs with higher yields, and more versatile food applications including sweeteners, clean-label additives, and enzymes.

2Nutriba
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner logo displayed on GreenLab website indicating collaboration in the protein/nutrition space.

greenlab.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner logo displayed on GreenLab website indicating collaboration in the protein/ingredient space.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner logo displayed on GreenLab website indicating collaboration in testing or quality assurance.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner logo displayed on GreenLab website indicating collaboration in the protein/biotech space.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Agrivida is a direct predecessor and most relevant peer to GreenLab, developing corn-expressed enzymes for animal nutrition and industrial applications. Multiple GreenLab executives (Raab, Schley-Johnson, Bougri, Samoylov, Lessard) previously led Agrivida's corn expression work on phytase, glucanase, and intein switch technology — making it the closest technology analog.

TypeDirect peer
Description

Inari uses proprietary seed technology (including AI-driven design and multiplex gene editing) to develop crops that produce more with fewer inputs. It shares GreenLab's plant-based biotechnology approach and seed-level innovation model for agriculture-based solutions.

TypeEmerging player
Description

Pairwise uses CRISPR-based plant breeding to develop improved fruits, vegetables, and row crops, with a focus on traits for food and agriculture. While focused on gene editing rather than protein expression, it represents plant-based biotechnology applied to crop improvement relevant to GreenLab's space.

TypeDirect peer
Description

Amai Proteins produces sweet proteins using precision fermentation, including brazzein and other naturally sweet proteins. It is the most direct competitor to GreenLab's brazzein product, using a different production modality (microbial fermentation vs. corn expression) to address the same CPG sweetener market.

TypeBroad incumbent
Description

Perfect Day produces animal-free dairy proteins (whey, casein) via precision fermentation, serving food and nutrition CPG companies. It is a broad incumbent in alternative protein manufacturing with significant venture funding, competing for the same B2B ingredient partner relationships as GreenLab.

TypeEmerging player
Description

Brightseed uses AI to discover bioactive compounds in plants for health and nutrition applications. It overlaps with GreenLab's customer base (CPG, nutraceutical) and shares a thesis that plant-based ingredients address major health/wellness markets, but focuses on discovery rather than manufacturing.

TypeEmerging player
Description

Shiru is both a partner and adjacent peer — an AI-powered protein discovery platform targeting the same CPG and food ingredient customers as GreenLab. Their March 2025 strategic partnership explicitly combines Shiru's discovery with GreenLab's manufacturing, making them complementary rather than purely competitive.

TypeBroad incumbent
Description

Geltor produces animal-free proteins (collagen, elastin, etc.) via precision fermentation for beauty, nutrition, and food applications. It is a well-funded incumbent in the alternative protein space competing for B2B ingredient partnerships similar to GreenLab's go-to-market.

TypeDirect peer
Description

Elo Life Systems develops plant-based ingredients using crop biotechnology and precision fermentation for food, beverage, and nutrition markets. It shares GreenLab's plant-based approach and B2B ingredient supplier business model targeting CPG companies.

TypeEmerging player
Description

ChrysaLabs uses advanced sensors and AI for soil analysis and crop management — adjacent agricultural biotechnology infrastructure. While not a direct competitor in protein expression, it represents the broader agtech ecosystem in which GreenLab's corn-based platform operates.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles15 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

GreenLab

Plant-based Biomanufacturinggreenlab.com

GreenLab is a Jonesboro, Arkansas-based plant biotechnology company that uses proprietary corn-based protein expression technology (GVT) to produce sustainable proteins and enzymes for food, pharmaceutical, energy, environmental, and industrial B2B customers.

What GreenLab does

GreenLab is a plant-based biotechnology company headquartered in Jonesboro, Arkansas, that uses proprietary corn-based protein expression technology to convert cornfields into scalable protein manufacturing facilities. Its core platform, GreenLab Vector Technology (GVT), is a vector system that transfers and expresses recombinant proteins directly in corn plants at yields the company claims are up to 100X higher than traditional methodologies. The company has transferred nearly 20 proteins into corn, has four or more patented enzymes in commercial production, and has been developing brazzein (a naturally occurring sweet protein) as a sustainable sugar-replacement ingredient for food formulators.

GreenLab serves enterprise B2B customers across food and beverage, pharmaceutical/nutraceutical, energy/industrial, and environmental remediation sectors. Revenue mechanics are structured around licensing its protein expression technology, direct sales of proprietary proteins and enzymes, and strategic production partnerships (most notably the March 2025 alliance with AI-protein-discovery company Shiru targeting CPG customers). The GTM motion is enterprise field sales supplemented by partnership channels and a private investor/partner portal. Pricing is not publicly disclosed and is negotiated through custom B2B arrangements.

The company has disclosed approximately $5.27M in seed funding (January 2023, Northeast Arkansas agricultural investors) and an additional $1.91M round (April 2025), with stated total investment of approximately $8M to reach commercial readiness. The leadership team is anchored by co-founders and senior scientists from Agrivida (including CTO Michael Raab and VP Jeremy Schley-Johnson), with additional expertise drawn from Monsanto, Syngenta, Cargill, Nestlé, and Goldman Sachs. The company remains privately held with 1-10 employees and operates from a single U.S. location.

GreenLab firmographics

Firmographics
Name
GreenLab
Legal name
GreenLab, Inc.
Website
https://greenlab.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
1–10 employees
Short description
GreenLab is a Jonesboro, Arkansas-based plant biotechnology company that uses proprietary corn-based protein expression technology (GVT) to produce sustainable proteins and enzymes for food, pharmaceutical, energy, environmental, and industrial B2B customers.
Ownership category
akta.pro rank

GreenLab industry classification

Industry
Product category
Plant-based Biomanufacturing
NAICS
Food Manufacturing (311)
SIC
Food And Kindred Products (2000), Medicinal Chemicals & Botanical Products (2833)
akta.pro primary industry
Plant-Based & Alternative Proteins (Packaged) (CRADAAAH)
akta.pro secondary industries
Enzymes & Processing Aids (Baking, Brewing, Dairy, Meat) (CRADAOAH), Specialty & Novel Proteins (Single-Cell Protein, Cell-Cultured/Animal-Free Proteins) (AFAJAHAL)

Keywords

  • Plant-based protein production
  • Corn-based protein expression
  • Recombinant enzyme manufacturing
  • Agricultural biotechnology platform
  • Natural sweetener brazzein

Where GreenLab is headquartered

Location

Headquarters

HQ city
Jonesboro
HQ country
United States
HQ region
North America

Offices1 record

Markets served

GreenLab business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Protein and Enzyme Licensing/Sales: GreenLab generates revenue through licensing its proprietary corn-based protein expression technology and direct sales of proteins and enzymes produced in commercial corn production. The company sells its proprietary portfolio directly to partners and also seeks to expand manufacturing capacity for other protein manufacturers.
  2. Partner Production Services: Revenue generated through strategic partnerships where GreenLab provides protein production optimization services using its scalable corn expression system. Partners gain access to high-yield, scalable manufacturing that extends beyond traditional microbial and precision fermentation approaches.
  3. Technology Platform Licensing: The GVT platform is offered to eliminate production backlog for protein designers and enzyme engineers, with collaboration opportunities for manufacturers to grow proteins to scale. The technology enables unlimited scalability over time.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

GreenLab product offering

Product offering

Core offering

GreenLab develops and operates a proprietary corn-based protein expression platform (GreenLab Vector Technology, GVT) that converts traditional cornfields into scalable bioreactors for manufacturing recombinant proteins and enzymes. The company sells and licenses its corn-grown protein portfolio directly to enterprise customers, including the natural high-intensity sweetener Brazzein and multiple patented enzymes in commercial production, and offers partner production services for protein designers, enzyme engineers, and biomanufacturers in food, pharmaceutical, nutraceutical, energy, environmental remediation, and industrial markets.

Product overview

GreenLab is a biotechnology company that has developed a proprietary plant-based protein expression platform using corn as a biofactory. The company offers a unified platform technology (GreenLab Vector Technology) combined with commercial products including Brazzein (a natural sweet protein) and multiple enzymes. The platform transforms cornfields into scalable protein manufacturing facilities, enabling the sustainable production of high-value proteins for food, nutrition, and industrial applications. The company has successfully transferred nearly 20 proteins into corn and has multiple patented enzymes already in commercial production.

Differentiator

Problem solved

Functional benefit

Products and services

  • Brazzein A naturally occurring high-intensity sweet protein originally found in the West African oubli plant, sustainably produced through GreenLab's proprietary corn-based expression system. Brazzein is offered as a nutritive sweetener for food formulators and food service partners, providing production capacity, reduced sugar use with health benefits, and recipe formulation flexibility for CPG and beverage manufacturers.
  • GreenLab Vector Technology (GVT) Platform A proprietary corn-based protein expression platform licensed to protein designers, enzyme engineers, and biomanufacturers across energy, food, pharma, environmental remediation, and industrial sectors. The platform enables yields up to 100X higher activity than traditional methodologies, offers unlimited scalability across acres of conventional cornfields, and eliminates production backlog by extending manufacturing beyond microbial and precision fermentation.
  • Commercial Enzymes (Corn-Grown) Multiple transformative enzymes produced commercially through GreenLab's patented corn-grown protein system. The company has scaled commercial production of several enzymes and currently has four patented enzymes growing in corn in commercial production, serving food, industrial, and animal nutrition applications.

Quantifiable outcome

  • 100X higher activity yields than traditional protein expression methodologies
  • +2 more outcomes

Companies that use GreenLab

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles4 records

GreenLab technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

GreenLab partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • ShirucoreStrategic or Co-development Partner · 12 March 2025Strategic partnership to commercialize novel food proteins using GreenLab's proprietary corn expression system. The collaboration combines Shiru's AI-powered protein discovery with GreenLab's high-yield, scalable manufacturing platform that extends beyond microbial and precision fermentation. Initial focus directed at CPG companies. Benefits include faster ingredient innovation, scalable cost-effective production, lower costs with higher yields, and more versatile food applications including sweeteners, clean-label additives, and enzymes.
  • NutribaminorStrategic or Co-development PartnerPartner logo displayed on GreenLab website indicating collaboration in the protein/nutrition space.
  • GROminorStrategic or Co-development PartnerPartner logo displayed on GreenLab website indicating collaboration in the protein/ingredient space.
  • CPT (Consumer Product Testing)minorStrategic or Co-development PartnerPartner logo displayed on GreenLab website indicating collaboration in testing or quality assurance.
  • CorvusminorStrategic or Co-development PartnerPartner logo displayed on GreenLab website indicating collaboration in the protein/biotech space.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

GreenLab competitors and assessment

Company assessment

Direct peers

  • Agrivida: Agrivida is a direct predecessor and most relevant peer to GreenLab, developing corn-expressed enzymes for animal nutrition and industrial applications. Multiple GreenLab executives (Raab, Schley-Johnson, Bougri, Samoylov, Lessard) previously led Agrivida's corn expression work on phytase, glucanase, and intein switch technology — making it the closest technology analog.
  • Inari Agriculture: Inari uses proprietary seed technology (including AI-driven design and multiplex gene editing) to develop crops that produce more with fewer inputs. It shares GreenLab's plant-based biotechnology approach and seed-level innovation model for agriculture-based solutions.
  • Amai Proteins: Amai Proteins produces sweet proteins using precision fermentation, including brazzein and other naturally sweet proteins. It is the most direct competitor to GreenLab's brazzein product, using a different production modality (microbial fermentation vs. corn expression) to address the same CPG sweetener market.
  • Elo Life Systems: Elo Life Systems develops plant-based ingredients using crop biotechnology and precision fermentation for food, beverage, and nutrition markets. It shares GreenLab's plant-based approach and B2B ingredient supplier business model targeting CPG companies.

Emerging players

  • Pairwise: Pairwise uses CRISPR-based plant breeding to develop improved fruits, vegetables, and row crops, with a focus on traits for food and agriculture. While focused on gene editing rather than protein expression, it represents plant-based biotechnology applied to crop improvement relevant to GreenLab's space.
  • Brightseed: Brightseed uses AI to discover bioactive compounds in plants for health and nutrition applications. It overlaps with GreenLab's customer base (CPG, nutraceutical) and shares a thesis that plant-based ingredients address major health/wellness markets, but focuses on discovery rather than manufacturing.
  • Shiru: Shiru is both a partner and adjacent peer — an AI-powered protein discovery platform targeting the same CPG and food ingredient customers as GreenLab. Their March 2025 strategic partnership explicitly combines Shiru's discovery with GreenLab's manufacturing, making them complementary rather than purely competitive.
  • ChrysaLabs: ChrysaLabs uses advanced sensors and AI for soil analysis and crop management — adjacent agricultural biotechnology infrastructure. While not a direct competitor in protein expression, it represents the broader agtech ecosystem in which GreenLab's corn-based platform operates.

Broad incumbents

  • Perfect Day: Perfect Day produces animal-free dairy proteins (whey, casein) via precision fermentation, serving food and nutrition CPG companies. It is a broad incumbent in alternative protein manufacturing with significant venture funding, competing for the same B2B ingredient partner relationships as GreenLab.
  • Geltor: Geltor produces animal-free proteins (collagen, elastin, etc.) via precision fermentation for beauty, nutrition, and food applications. It is a well-funded incumbent in the alternative protein space competing for B2B ingredient partnerships similar to GreenLab's go-to-market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

GreenLab social profiles

Digital presence

GreenLab financial estimates

Financial estimate

Revenue estimate

Valuation estimate

GreenLab leadership team

Management profile

Number of profiles

Profiles15 records

GreenLab funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

GreenLab M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GreenLab

What does GreenLab do?

GreenLab develops and operates a proprietary corn-based protein expression platform (GreenLab Vector Technology, GVT) that converts traditional cornfields into scalable bioreactors for manufacturing recombinant proteins and enzymes. The company sells and licenses its corn-grown protein portfolio directly to enterprise customers, including the natural high-intensity sweetener Brazzein and multiple patented enzymes in commercial production, and offers partner production services for protein designers, enzyme engineers, and biomanufacturers in food, pharmaceutical, nutraceutical, energy, environmental remediation, and industrial markets.

Is GreenLab a public or private company?

GreenLab is a private company. It is classified as venture growth investor backed and is currently operating.

When was GreenLab founded?

GreenLab was founded in 2005. It employs 1 to 10 people.

Where is GreenLab based?

GreenLab is headquartered in Jonesboro, United States, in the North America region.

How does GreenLab make money?

Three revenue lines are on record. Protein and Enzyme Licensing/Sales are the primary driver. The others are partner Production Services and technology Platform Licensing.

Who are GreenLab's main competitors?

Direct peers on record are Agrivida, Inari Agriculture, Amai Proteins and Elo Life Systems. Emerging players are Pairwise, Brightseed, Shiru and ChrysaLabs. Broad incumbents are Perfect Day and Geltor.

Does GreenLab have an API?

No public API is recorded for GreenLab.

What industry is GreenLab in?

GreenLab's product category is Plant-based Biomanufacturing. Its primary akta.pro industry code is CRADAAAH, Plant-Based & Alternative Proteins (Packaged), with a secondary code of CRADAOAH, Enzymes & Processing Aids (Baking, Brewing, Dairy, Meat). Its NAICS code is 311 and its SIC code is 2000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ArkansasbusinessNortheast Arkansas Farmers Are Growing Corn That Could Replace SugarGreenLab Inc., a Jonesboro startup, raised over $10 million to produce a corn-based sugar substitute using brazzein, a protein up to 2,500 times sweeter than sugar. The company extracts the protein from genetically modified corn, creating a no-calorie, gluten-free alternative. It aims to scale production if demand grows.GreenlabShiru and GreenLab Partner to Scale Sustainable Protein Production Through Novel Corn-Based Expression SystemShiru and GreenLab have partnered to develop a sustainable protein production system using a novel corn-based expression mechanism. This partnership aims to enhance the scalability of sustainable protein production for food applications. The collaboration reflects a growing interest in innovative solutions to produce protein sustainably.Food Business NewsBrazzein sweetener created from corn kernelsGinkgo Bioworks and GreenLab have partnered to commercially produce brazzein, a natural sweetener, using corn kernels as a production medium. The collaboration leverages Ginkgo's protein expression services and GreenLab's proprietary plant biotechnology to scale manufacturing with minimal additional infrastructure.SecSEC FORM DGreenLab, Inc. filed a Form D with the SEC to report an exempt offering of equity securities under Rule 506(b). The company has raised $1,611,006 out of a total target offering amount of $2,100,000 from 24 investors as of March 1, 2024.PR NewswireGreenLab Vector Technology Platform Launch Offers New Unlimited Scaling Capacity for Designer Protein ManufacturingGreenLab, Inc. announced the launch of its proprietary GreenLab Vector Technology (GVT) platform for recombinant protein manufacturing, using cornfields as scalable production systems to transform novel proteins into commercial-scale output. The platform enables protein designers and manufacturers to achieve yields up to 100X higher activity than traditional methods while addressing economic and sustainability constraints that have slowed market growth. GreenLab is currently growing proteins including brazzein in corn with four case study enzymes in commercial production and is seeking partners across energy, food, pharma, environmental remediation, and industrial sectors.FinSMEsGreenLab Closes $5.26M in Seed FundingGreenLab, a biotech company based in Jonesboro, Arkansas, has closed $5.26 million in seed funding to accelerate growth and expand operations. The company currently produces four patented enzymes grown in corn and is actively seeking partners for direct sales or production capacity expansion.GreenlabGreenLab Closes $5.2 Million Seed RoundGreenLab, Inc. has closed a seed funding round totaling $5.27 million from a group of investors based in Northeast Arkansas. The capital will support the biotech startup's proprietary platform for manufacturing proteins using optimized corn production. GreenLab currently has four patented enzymes in commercial production and is seeking partners to expand its portfolio.PR NewswireGreenLab Closes $5.2 Million Seed RoundGreenLab, Inc. has closed a $5.27 million seed funding round led by investors from Northeast Arkansas. The biotech startup utilizes a proprietary platform to optimize protein production within cornfields, currently having four patented enzymes in commercial production. The company is now seeking partners for direct sales, production collaboration, or capacity expansion.VC News DailyGreenLab Completes $5.2M Seed RoundGreenLab has successfully closed a $5.2 million seed funding round, supported by a diverse group of investors from Northeast Arkansas. The biotech startup aims to transform cornfields into sustainable production facilities through next-generation plant biotechnology, currently having four patented enzymes in commercial production.